130 related articles for article (PubMed ID: 20364298)
1. Growth inhibition, morphology change, and cell cycle alterations in NFBD1-depleted human esophageal cancer cells.
Yang Z; Bu Y; Wang C; Liu G; Song F
Mol Cell Biochem; 2010 Sep; 342(1-2):1-6. PubMed ID: 20364298
[TBL] [Abstract][Full Text] [Related]
2. Silencing of polo-like kinase (Plk) 1 via siRNA causes inhibition of growth and induction of apoptosis in human esophageal cancer cells.
Bu Y; Yang Z; Li Q; Song F
Oncology; 2008; 74(3-4):198-206. PubMed ID: 18714168
[TBL] [Abstract][Full Text] [Related]
3. NFBD1/MDC1 is a protein of oncogenic potential in human cervical cancer.
Yuan C; Bu Y; Wang C; Yi F; Yang Z; Huang X; Cheng L; Liu G; Wang Y; Song F
Mol Cell Biochem; 2012 Jan; 359(1-2):333-46. PubMed ID: 21853275
[TBL] [Abstract][Full Text] [Related]
4. Depletion of NFBD1/MDC1 Induces Apoptosis in Nasopharyngeal Carcinoma Cells Through the p53-ROS-Mitochondrial Pathway.
Wang Z; Liao K; Zuo W; Liu X; Qiu Z; Gong Z; Liu C; Zeng Q; Qian Y; Jiang L; Bu Y; Hong S; Hu G
Oncol Res; 2017 Jan; 25(1):123-136. PubMed ID: 28081741
[TBL] [Abstract][Full Text] [Related]
5. Loss of NFBD1/MDC1 disrupts homologous recombination repair and sensitizes nasopharyngeal carcinoma cells to PARP inhibitors.
Wang Z; Zuo W; Zeng Q; Qian Y; Li Y; Liu C; Wang J; Zhong S; Bu Y; Hu G
J Biomed Sci; 2019 Feb; 26(1):14. PubMed ID: 30717758
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of NFBD1/MDC1 enhances chemosensitivity to cisplatin or 5-fluorouracil in nasopharyngeal carcinoma CNE1 cells.
Zeng Q; Wang Z; Liu C; Gong Z; Yang L; Jiang L; Ma Z; Qian Y; Yang Y; Kang H; Hong S; Bu Y; Hu G
Mol Cell Biochem; 2016 Jul; 418(1-2):137-46. PubMed ID: 27334757
[TBL] [Abstract][Full Text] [Related]
7. NFBD1/MDC1 stabilizes oncogenic MDM2 to contribute to cell fate determination in response to DNA damage.
Inoue K; Nakanjishi M; Kikuchi H; Yamamoto H; Todo S; Nakagawara A; Ozaki T
Biochem Biophys Res Commun; 2008 Jul; 371(4):829-33. PubMed ID: 18471438
[TBL] [Abstract][Full Text] [Related]
8. NFBD1/MDC1 participates in the regulation of G2/M transition in mammalian cells.
Bu Y; Suenaga Y; Okoshi R; Sang M; Kubo N; Song F; Nakagawara A; Ozaki T
Biochem Biophys Res Commun; 2010 Jun; 397(2):157-62. PubMed ID: 20529673
[TBL] [Abstract][Full Text] [Related]
9. NFBD1/MDC1, 53BP1 and BRCA1 have both redundant and unique roles in the ATM pathway.
Wilson KA; Stern DF
Cell Cycle; 2008 Nov; 7(22):3584-94. PubMed ID: 19001859
[TBL] [Abstract][Full Text] [Related]
10. NFBD1/MDC1 associates with p53 and regulates its function at the crossroad between cell survival and death in response to DNA damage.
Nakanishi M; Ozaki T; Yamamoto H; Hanamoto T; Kikuchi H; Furuya K; Asaka M; Delia D; Nakagawara A
J Biol Chem; 2007 Aug; 282(31):22993-3004. PubMed ID: 17535811
[TBL] [Abstract][Full Text] [Related]
11. 53BP1 and NFBD1/MDC1-Nbs1 function in parallel interacting pathways activating ataxia-telangiectasia mutated (ATM) in response to DNA damage.
Mochan TA; Venere M; DiTullio RA; Halazonetis TD
Cancer Res; 2003 Dec; 63(24):8586-91. PubMed ID: 14695167
[TBL] [Abstract][Full Text] [Related]
12. NFBD1, like 53BP1, is an early and redundant transducer mediating Chk2 phosphorylation in response to DNA damage.
Peng A; Chen PL
J Biol Chem; 2003 Mar; 278(11):8873-6. PubMed ID: 12551934
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitor FK228 activates tumor suppressor Prdx1 with apoptosis induction in esophageal cancer cells.
Hoshino I; Matsubara H; Hanari N; Mori M; Nishimori T; Yoneyama Y; Akutsu Y; Sakata H; Matsushita K; Seki N; Ochiai T
Clin Cancer Res; 2005 Nov; 11(21):7945-52. PubMed ID: 16278420
[TBL] [Abstract][Full Text] [Related]
14. Sp1-mediated transcriptional regulation of NFBD1/MDC1 plays a critical role in DNA damage response pathway.
Bu Y; Suenaga Y; Ono S; Koda T; Song F; Nakagawara A; Ozaki T
Genes Cells; 2008 Jan; 13(1):53-66. PubMed ID: 18173747
[TBL] [Abstract][Full Text] [Related]
15. NFBD1/MDC1 participates in the regulation of proliferation and apoptosis in human laryngeal squamous cell carcinoma.
Liu X; Qiu Z; Wang Z; Zuo W; Gong Z; Liu C; Zeng Q; Qian Y; Jiang L; Li Y; Bu Y; Hu G
Clin Transl Oncol; 2018 Apr; 20(4):534-541. PubMed ID: 28921460
[TBL] [Abstract][Full Text] [Related]
16. [Expression of DNA damage checkpoint mediator 1 and p53-binding protein 1 in human esophageal cancer cell lines TE-1, TE-13, and Eca109].
Liu ZK; Zhu SC; Wang YX
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1314-7. PubMed ID: 17884766
[TBL] [Abstract][Full Text] [Related]
17. A key role for early growth response-1 and nuclear factor-kappaB in mediating and maintaining GRO/CXCR2 proliferative signaling in esophageal cancer.
Wang B; Khachigian LM; Esau L; Birrer MJ; Zhao X; Parker MI; Hendricks DT
Mol Cancer Res; 2009 May; 7(5):755-64. PubMed ID: 19435811
[TBL] [Abstract][Full Text] [Related]
18. NFBD1, a novel nuclear protein with signature motifs of FHA and BRCT, and an internal 41-amino acid repeat sequence, is an early participant in DNA damage response.
Shang YL; Bodero AJ; Chen PL
J Biol Chem; 2003 Feb; 278(8):6323-9. PubMed ID: 12475977
[TBL] [Abstract][Full Text] [Related]
19. Silencing NFBD1/MDC1 enhances the radiosensitivity of human nasopharyngeal cancer CNE1 cells and results in tumor growth inhibition.
Wang Z; Zeng Q; Chen T; Liao K; Bu Y; Hong S; Hu G
Cell Death Dis; 2015 Aug; 6(8):e1849. PubMed ID: 26247734
[TBL] [Abstract][Full Text] [Related]
20. TPX2 siRNA regulates growth and invasion of esophageal cancer cells.
Liu HC; Zhang GH; Liu YH; Wang P; Ma JF; Su LS; Li SL; Zhang L; Liu JW
Biomed Pharmacother; 2014 Sep; 68(7):833-9. PubMed ID: 25239289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
